Skip to main content

Table 4 Observed case analysis of patients free of disability at specified times post-dose for selected attacks

From: Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study

 

Time point

Lasmiditan 100 mga

n/N (%)

Lasmiditan 200 mga

n/N (%)

Overalla

n/N (%)

Attack 1

Baseline

16/931 (1.7)

26/963 (2.7)

42/1894 (2.2)

0.5 h

60/797 (7.5)

53/828 (6.4)

113/1625 (7.0)

1 h

176/814 (21.6)

183/846 (21.6)

359/1660 (21.6)

2 h

327/847 (38.6)

341/869 (39.2)

668/1716 (38.9)

4 h

385/585 (65.8)

429/677 (63.4)

814/1262 (64.5)

24 h

374/432 (86.6)

420/495 (84.8)

794/927 (85.7)

48 h

365/414 (88.2)

436/504 (86.5)

801/918 (87.3)

Attack 5

Baseline

5/560 (0.9)

5/566 (0.9)

10/1126 (0.9)

0.5 h

28/477 (5.9)

21/491 (4.3)

49/968 (5.1)

1 h

80/484 (16.5)

89/510 (17.5)

169/994 (17.0)

2 h

189/505 (37.4)

194/504 (38.5)

383/1009 (38.0)

4 h

233/345 (67.5)

249/372 (66.9)

482/717 (67.2)

24 h

232/271 (85.6)

249/299 (83.3)

481/570 (84.4)

48 h

243/271 (89.7)

239/286 (83.6)

482/557 (86.5)

Attack 10

Baseline

2/324 (0.6)

4/298 (1.3)

6/622 (1.0)

0.5 h

11/275 (4.0)

14/262 (5.3)

25/537 (4.7)

1 h

41/281 (14.6)

48/263 (18.3)

89/544 (16.4)

2 h

85/285 (29.8)

98/269 (36.4)

183/554 (33.0)

4 h

109/172 (63.4)

133/192 (69.3)

242/364 (66.5)

24 h

100/130 (76.9)

116/140 (82.9)

216/270 (80.0)

48 h

108/121 (89.3)

116/138 (84.1)

224/259 (86.5)

Attack 15

Baseline

1/193 (0.5)

0/174 (0)

1/367 (0.3)

0.5 h

6/154 (3.9)

6/145 (4.1)

12/299 (4.0)

1 h

15/157 (9.6)

25/146 (17.1)

40/303 (13.2)

2 h

43/172 (25.0)

57/156 (36.5)

100/328 (30.5)

4 h

54/97 (55.7)

65/104 (62.5)

119/201 (59.2)

24 h

57/69 (82.6)

81/90 (90.0)

138/159 (86.8)

48 h

63/76 (82.9)

71/85 (83.5)

134/161 (83.2)

Attack 20

Baseline

2/116 (1.7)

0/108 (0)

2/224 (0.9)

0.5 h

1/98 (1.0)

4/95 (4.2)

5/193 (2.6)

1 h

12/104 (11.5)

17/92 (18.5)

29/196 (14.8)

2 h

25/103 (24.3)

36/94 (38.3)

61/197 (31.0)

4 h

28/52 (53.8)

40/59 (67.8)

68/111 (61.3)

24 h

33/44 (75.0)

41/51 (80.4)

74/95 (77.9)

48 h

35/42 (83.3)

43/52 (82.7)

78/94 (83.0)

  1. Abbreviations: n = number of patients in category; N = number of patients with data available
  2. Based on electronic diary question “How much is your migraine interfering with your normal activities.” Response options were “not at all,” “mild interference,” “marked interference,” and “need complete bed rest”. Data shown for “not at all” (no disability). Analysis of “interference with normal activities” during the course of each attack included all patients who took study medication and reported interference values at each time point
Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us